Two cases of delayed onset of immune‐related adverse events after discontinuation of nivolumab in patients with metastatic renal cell cancer

INTRODUCTION: Delayed onset of immune‐related adverse events following immune‐checkpoint inhibitor discontinuation is underrecognized because of little available evidence. CASE PRESENTATION: A 50‐year‐old man with metastatic renal cell carcinoma (Case 1) and 58‐year‐old woman with renal cell carcino...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakai, Yasutomo, Otsuka, Tomoyuki, Inoue, Takako, Nawa, Takatoshi, Hatano, Koji, Yamamoto, Yoshiyuki, Nagahara, Akira, Nakayama, Masashi, Kakimoto, Ken‐ichi, Nishimura, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413213/
https://www.ncbi.nlm.nih.gov/pubmed/34497995
http://dx.doi.org/10.1002/iju5.12338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413213/
https://www.ncbi.nlm.nih.gov/pubmed/34497995
http://dx.doi.org/10.1002/iju5.12338

Ejemplares similares